|
Index of reports
> Cases resulting in death (6)
Below is the selection of adverse event reports related to Vesanoid (Tretinoin Oral) that includes cases resulting in death.
Adverse event in 65 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-10-31
Patient: 65 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Pulmonary Alveolar Haemorrhage
Adverse event resulted in: death
Suspect drug(s):
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2007-07-09
End date: 2007-07-10
Gran
Dosage: route: injectable (not otherwise specified). generic name: filgrastim (genetical recombination).
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-06
End date: 2007-07-10
Other drugs received by patient: Cylocide; Idamycin; Diflucan; Radicut
Adverse event in 65 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-10-26
Patient: 65 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Pulmonary Alveolar Haemorrhage
Adverse event resulted in: death
Suspect drug(s):
Vesanoid
Dosage: 30mg in the daytime, 20 mg in the evening
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2007-07-09
End date: 2007-07-09
Vesanoid
Administration route: Oral
Start date: 2007-07-10
End date: 2007-07-10
Gran
Dosage: route: injectable (not otherwise specified). generic name: filgrastim (genetical recombination).
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-06
End date: 2007-07-10
Other drugs received by patient: Cylocide; Idamycin; Diflucan
Adverse event in 65 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-10-16
Patient: 65 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Respiratory Failure, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: death
Suspect drug(s):
Vesanoid
Dosage: 30mg in the daytime, 20 mg in the evening
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2007-07-09
End date: 2007-07-09
Vesanoid
Administration route: Oral
Start date: 2007-07-10
End date: 2007-07-10
Gran
Dosage: route: injectable (not otherwise specified). generic name: filgrastim (genetical recombination).
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-05
Other drugs received by patient: Cylocide; Idamycin; Diflucan
Adverse event in 34 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from United States on 2007-10-10
Patient: 34 year old male, weighing 61.2 kg (134.6 pounds)
Adverse reactions / side effects: Heart Rate Decreased, Cardio-Respiratory Arrest, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Adverse event in 19 year old female receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from United States on 2007-06-13
Patient: 19 year old female, weighing 74.5 kg (163.9 pounds)
Adverse reactions / side effects: Retinoic Acid Syndrome, Respiratory Failure, Disseminated Intravascular Coagulation, Hypoxia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Vesanoid
Start date: 2007-04-22
End date: 2007-04-23
Vesanoid
Dosage: 40mg every 12 hours
Start date: 2007-04-12
End date: 2007-04-13
Other drugs received by patient: Idarubicin HCL
Adverse event in 11 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-03-12
Patient: 11 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Retinoic Acid Syndrome, Haemorrhage Intracranial
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Other drugs received by patient: Cytarabine; Daunorubicin HCL; Allopurinol; Baktar; Kytril
|
